Advanced Pain Remedies is a biotechnology company focused on treating intractable chronic pain. The company is led by an experienced management team.
Advanced Pain Remedies is a wholly owned subsidiary of Cato BioVentures. The company’s lead compound, APR 102, is a substance P-saporin (SP-SAP) conjugate that has shown efficacy in animal models of pain. Please visit our Product page for more information on APR 102.